Please provide your email address to receive an email when new articles are posted on . IVUS may improve care of patients undergoing peripheral revascularization. More data are needed to document ...

There were tradeoffs for early adopters going the transradial route for infrainguinal peripheral artery intervention, ...

Please provide your email address to receive an email when new articles are posted on . In a cohort of patients with renal impairment who underwent peripheral revascularization, rivaroxaban reduced ...

Compared with dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose cotransporter 2 (SGLT2) inhibitors were associated with lower risks of cardiac death and composite renal outcomes without ...

Results from the largest real-world propensity-matched comparison to date show that radial-to-peripheral (R2P) access ...

Lower-extremity peripheral artery disease affects more than 200 million people worldwide. Patients who undergo peripheral revascularization are at high risk for subsequent complications; their risk ...

WASHINGTON, DC—Vascular interventions in patients with PAD are associated with comparable short-term outcomes no matter whether they’re performed via radial or femoral access, according to early ...

"Our findings highlight the clinical importance of focusing on total disease burden, rather than first events, and the need for long-term preventive strategies in high-risk patients."—Michael Szarek, ...

Compared with white patients, Black patients with PAD who undergo peripheral revascularization have much more advanced disease at the time of their procedures and are less likely to receive necessary ...

A trio of new studies is prompting a rethink of musculoskeletal care, from questioning the benefits of partial meniscectomy ...